Huang, R. Y., Wong, M. K., Tan, T. Z., Kuay, K. T., Ng, A. H. C., Chung, V. Y., . . . Thiery, J. P. (2013). An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Nature Publishing Group.
Chicago Style CitationHuang, R Y-J, et al. An EMT Spectrum Defines an Anoikis-resistant and Spheroidogenic Intermediate Mesenchymal State That Is Sensitive to E-cadherin Restoration By a Src-kinase Inhibitor, Saracatinib (AZD0530). Nature Publishing Group, 2013.
Cita MLAHuang, R Y-J, et al. An EMT Spectrum Defines an Anoikis-resistant and Spheroidogenic Intermediate Mesenchymal State That Is Sensitive to E-cadherin Restoration By a Src-kinase Inhibitor, Saracatinib (AZD0530). Nature Publishing Group, 2013.